Royalty Pharma Plc (NASDAQ:RPRX) is one of the best healthcare stocks under $50 to invest in. On January 30, Royalty Pharma Plc (NASDAQ:RPRX) was upgraded to Buy from Neutral by UBS, with the firm raising the price target on the stock to $49 from $38. The firm told investors that Royalty Pharma Plc (NASDAQ:RPRX) has delivered a series of attractive royalty deals, “meaningfully” bolstering its growth profile. UBS sees a “catalyst-rich” 2026 for the company, with the potential of driving “significant stock u ...

Moderna, Inc. (NASDAQ:MRNA) is one of the best healthcare stocks under $50 to invest in. Morgan Stanley reiterated a Hold rating on Moderna, Inc. (NASDAQ:MRNA) on February 2, setting a price target of $28.00. In a separate development, Moderna, Inc. (NASDAQ:MRNA) announced on January 29 a strategic collaboration with Recordati for the advancement of the former’s investigational propionic acidemia therapeutic, mRNA-3927, through the final stages of clinical development and global commercialization upon appr ...

Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best healthcare stocks under $50 to invest in. TD Cowen maintained a bullish outlook on Roivant Sciences Ltd. (NASDAQ:ROIV) on February 6, revising the price target on the stock to $38 from $28 and maintaining a Buy rating. The rating update came the same day Roivant Sciences Ltd. (NASDAQ:ROIV) announced positive Phase 2 results for brepocitinib in cutaneous sarcoidosis (CS) and reported its financial results for Q3 ended December 31, 2025. WhyRoivant Scie ...

Viatris Inc. (NASDAQ:VTRS) is one of the best healthcare stocks under $50 to invest in. Viatris Inc. (NASDAQ:VTRS) received a rating update from Piper Sandler on January 28, which adjusted the price target on the stock to $12 from $9 while maintaining a Neutral rating on the shares. The rating update came ahead of the quarterly results, with the firm citing strength for the brand business across a range of geographies, along with the possibility of continued steady contribution in developed markets from ne ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best healthcare stocks under $50 to invest in. Barclays maintained an Overweight rating on Teva Pharmaceutical Industries Limited (NYSE:TEVA) on January 30, adjusting the price target on the stock to $38 from $35. It told investors that it updated the company’s model after the fiscal Q4 report, and expressed confidence in the shares at these levels. Teva Pharmaceutical Industries Limited (TEVA): Among Small-Cap Healthcare Stocks Hedge Funds ...

Nvidia stock is now hovering near its highest levels this year so far. ...

Plus, it's a big investing world out there ...

Ripple is aiming to use XRP (CRYPTO: XRP) to do something that crypto rarely pulls off: make decentralized finance (DeFi) usable -- and useful -- for financial institutions. And in service of that goal, on Feb. 4, the company announced that its Ripple Prime platform now supports integration with Hyperliquid (CRYPTO: HYPE), a major crypto exchange for financial derivatives and tokenized real-world assets. This is the kind of move that could potentially supercharge XRP's price for quite some time. Here's wh ...

Core Viewpoint - Oil India reported a decline in third-quarter profit due to lower realizations impacting margins, despite an increase in fuel demand [1] Company Summary - Oil India experienced a fall in profit for the third quarter, indicating challenges in maintaining profitability amidst fluctuating market conditions [1] - The company faced squeezed margins, which were primarily attributed to lower realizations, despite the backdrop of higher fuel demand [1] Industry Summary - The oil and gas industry is currently experiencing a complex environment where demand for fuel is rising, yet companies are struggling with profit margins due to pricing pressures [1]

Core Insights - CrowdStrike Holdings, Inc. (NASDAQ:CRWD) is recognized as one of the 10 AI stocks analysts are monitoring, particularly following a memorandum of understanding (MoU) with Aramco aimed at enhancing cybersecurity investments in Saudi Arabia [1][3]. Group 1: Collaboration with Aramco - The MoU with Aramco is a nonbinding agreement that signifies a potential multi-year collaboration aligned with Saudi Vision 2030, which seeks to diversify the economy and reduce oil dependency [3]. - CrowdStrike's CEO, George Kurtz, expressed pride in collaborating with Aramco to support secure AI adoption in Saudi Arabia, emphasizing the importance of securing the economy's growth [2]. Group 2: Strategic Initiatives - CrowdStrike plans to establish its headquarters in Saudi Arabia and has announced a regional cloud deployment, which is essential for scaling the partnership with Aramco [2]. - The company is also expanding its cloud deployments in Saudi Arabia, India, and the United Arab Emirates, enhancing its Global Data Sovereignty initiative [4]. Group 3: Analyst Support - Following the announcement of the collaboration with Aramco, analysts have shown support for CrowdStrike, with Cantor Fitzgerald reiterating an Overweight rating on the stock [1].